Federal Circuit vacates PTAB rejection of Ariosa IPR
In a decision that raises questions about the Patent Trial and Appeal Board's ability to complete IPRs within its one-year statutory deadline, the Federal Circuit has vacated a rejection of an IPR on the ground that the Board may have failed to sufficiently consider evidence
In today's holding in Ariosa Diagnostics v Verinata Health, the Federal Circuit vacated the Patent Trial and Appeal Board(PTAB)'s rejection of Ariosa's inter partes review challenge to Verinata's patent.
The court found that the language in the Board's decision made...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.